ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,602.97
      -0.55%
      US Tech 100
      19,888.80
      -1.14%
      Dow Jones
      39,783.90
      0.16%
      Brent Oil
      85.135
      0.10%
      Bitcoin
      57,807.30
      0.09%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. AMEX
      6. NovaBay Pharmaceuticals Inc New (NBY)

      7. NovaBay Pharmaceuticals Inc New (NBY) News

      NBY

      NovaBay Pharmaceuticals (NBY)

      NovaBay Pharmaceuticals Inc New
      		Date:
      Sort by:
       Showing the most relevant articles for your search:AMEX:NBY
      DateTimeSourceHeadlineSymbolCompany
      12:21PMiHub NewswireFeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing
      07/11/20248:50AMEdgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesAMEX:NBYNovaBay Pharmaceuticals Inc New
      07/11/20248:45AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:NBYNovaBay Pharmaceuticals Inc New
      07/11/20246:50AMBusiness WireNovaBay Pharmaceuticals Reports Preliminary Second Quarter 2024 Net Revenue of $2.4 MillionAMEX:NBYNovaBay Pharmaceuticals Inc New
      07/10/20244:05PMEdgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesAMEX:NBYNovaBay Pharmaceuticals Inc New
      07/10/20249:30AMEdgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]AMEX:NBYNovaBay Pharmaceuticals Inc New
      06/28/20246:50AMBusiness WireNovaBay Pharmaceuticals Supports National Dry Eye Awareness Month with Multiple Avenova Product PromotionsAMEX:NBYNovaBay Pharmaceuticals Inc New
      06/14/20248:47AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:NBYNovaBay Pharmaceuticals Inc New
      06/07/20247:30AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:NBYNovaBay Pharmaceuticals Inc New
      06/07/20246:50AMBusiness WireNovaBay Pharmaceuticals Plan of Compliance Accepted by the NYSE AmericanAMEX:NBYNovaBay Pharmaceuticals Inc New
      05/31/20244:50PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:NBYNovaBay Pharmaceuticals Inc New
      05/31/20244:43PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]AMEX:NBYNovaBay Pharmaceuticals Inc New
      05/30/20249:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:NBYNovaBay Pharmaceuticals Inc New
      05/30/20249:29PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:NBYNovaBay Pharmaceuticals Inc New
      05/30/20249:27PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:NBYNovaBay Pharmaceuticals Inc New
      05/30/20249:24PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:NBYNovaBay Pharmaceuticals Inc New
      05/30/20249:17PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:NBYNovaBay Pharmaceuticals Inc New
      05/29/20245:27PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:NBYNovaBay Pharmaceuticals Inc New
      05/29/20245:22PMBusiness WireNovaBay Pharmaceuticals Announces Approval of All Proposals at its 2024 Annual Meeting of Stockholders and Provides Other Corporate UpdatesAMEX:NBYNovaBay Pharmaceuticals Inc New
      05/13/20248:30AMBusiness WireNovaBay Pharmaceuticals Launches Avenova Product Bundles for Individualized Relief from Multifactorial Dry Eye SymptomsAMEX:NBYNovaBay Pharmaceuticals Inc New
      05/09/20244:05PMBusiness WireNovaBay Pharmaceuticals Reports First Quarter 2024 Financial ResultsAMEX:NBYNovaBay Pharmaceuticals Inc New
      05/07/20248:00AMBusiness WireNovaBay Pharmaceuticals Announces Record Ordered Product Sales of Avenova-Branded Products in April through AmazonAMEX:NBYNovaBay Pharmaceuticals Inc New
      05/03/20246:50AMBusiness WireNovaBay Pharmaceuticals to Hold 2024 First Quarter Conference Call on May 9, 2024AMEX:NBYNovaBay Pharmaceuticals Inc New
      04/22/20246:57AMBusiness WireNovaBay Pharmaceuticals Announces New and Enhanced Direct-to-Consumer Marketing to Efficiently Engage Customers and Drive Avenova SalesAMEX:NBYNovaBay Pharmaceuticals Inc New
      04/19/20246:00PMBusiness WireNovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Stockholder EquityAMEX:NBYNovaBay Pharmaceuticals Inc New
      04/17/20246:59AMBusiness WireNovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing ExpensesAMEX:NBYNovaBay Pharmaceuticals Inc New
      03/26/20244:05PMBusiness WireNovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial ResultsAMEX:NBYNovaBay Pharmaceuticals Inc New
      03/25/20246:38PMBusiness WireNovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024AMEX:NBYNovaBay Pharmaceuticals Inc New
      03/14/20248:00AMBusiness WireNovaBay Pharmaceuticals Announces Agreement to Sell its DERMAdoctor Skincare Business Segment; Announces Preliminary Financial Results for Fourth Quarter and Year Ended December 31, 2023AMEX:NBYNovaBay Pharmaceuticals Inc New
      02/14/20242:52PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]AMEX:NBYNovaBay Pharmaceuticals Inc New
       Showing the most relevant articles for your search:AMEX:NBY